PBS-15
The first fully manufacturing-scale bioreactor using Vertical-Wheel® technology to scale proven processes for clinical and commercial needs. Generate larger batches, support clinical supply, and prepare for commercial scale on the next level of Vertical-Wheel bioreactors.

Why PBS-15
The PBS-15 is the next system on the clinical manufacturing scale. Once a process has been demonstrated at 3L scale with the PBS-3, the next challenge is producing enough cells to support clinical programs and commercial supply. The PBS-15 enables teams to increase batch size while maintaining the same Vertical-Wheel culture conditions, helping move from process development into routine manufacturing operations.
Produce clinically meaningful batches without changing platforms by maintain your proven Vertical-Wheel culture conditions.
Standardize every run with recipes, process control, and comprehensive data capture.
Designed for commercial manufacturing with single-use, cGMP-ready vessels and secure, audit-ready, 21 CFR Part 11-compliant software and IQ/OQ documentation.
Optimize an external ATF system to support high-density, closed system processing and intensified workflows.
The PBS-15 Vertical-Wheel FLUIDIX™ Vessel
The PBS-15 runs the pre-sterilized, single-use Vertical-Wheel FLUIDIX™ 15L vessel with the same wheel geometry as the systems below it, now at clinical batch scale.
Single-use sensors: measure, track, and control pH and DO through integrated optical sensors.

Proven With PBS-15
Published Vertical-Wheel data at this scale — protocols, app. notes, peer-reviewed papers, case studies, posters, webinars, etc.
The PBS Closed-System Sampling Conical supports aseptic, representative sample collection from PBS Vertical-Wheel® Bioreactors while maintaining process integrity and sample quality. The single-use assembly combines a gamma-irradiated vented conical, integrated dip tube, and weldable tubing to reduce contamination risk, handling steps, and operator variability. Compatible with stem cells, immune cells, organoids, and aggregate cultures, it supports routine in-process analyses including cell counts, viability testing, metabolite monitoring, and aggregate characterization.
This application note describes an hMSC manufacturing workflow using RoosterBio cell products, xeno-free media, and PBS Biotech Vertical-Wheel bioreactors. Studies evaluated microcarrier culture, fed-batch operation, harvest, scale-up, and cell quality. The low-shear, uniformly mixed environment supported robust attachment and cell densities up to 500,000 cells/mL within five days. Fed-batch processing improved media productivity by eliminating routine media exchanges and reducing labor. Comparable growth and metabolite control were maintained across development, pilot, and production…
This publication combines oxygen-transfer rate measurements through surface aeration for Vertical-Wheel bioreactors with specific oxygen-uptake measurements from human induced pluripotent stem cell aggregate cultures. Oxygen mass-transfer coefficients (kLa) were measured under different agitation rates, working volumes and headspace gas-flow conditions in 3, 15 and 80 L systems. The specific oxygen-uptake rate of iPSC aggregates was measured in a 0.1 L bioreactor using a custom dissolved oxygen probe configuration. These datasets were combined to estimate the theoretical maximum cell…
This publication characterizes power consumption in Vertical-Wheel® Bioreactors across multiple operating conditions. Studies evaluated how agitation rate, working volume, and vessel geometry influence energy input, mixing, and process scalability. Experimental measurements quantified power number relationships and established engineering correlations for bioprocess development and scale-up. The findings describe how Vertical-Wheel® Technology distributes energy throughout the culture environment while maintaining suspension and mixing efficiency. These experimentally derived hydrodynamic…
This publication examines upstream process challenges associated with scale-up of pluripotent stem cell cultures for commercial allogeneic cell therapy manufacturing. Key variables include seed train generation, hydrodynamics, aggregate morphology, oxygen transfer, carbon dioxide removal, medium exchange, and harvest. Computational fluid dynamics and experimental studies demonstrate the use of energy dissipation rate as a scale-up parameter for maintaining consistent aggregate morphology. The authors also present oxygenation and scalable medium exchange strategies to address process…
This publication characterizes Vertical-Wheel® Bioreactor hydrodynamics using computational fluid dynamics and biological validation with human induced pluripotent stem cell aggregates. The study evaluates velocity, energy dissipation rate, shear, and mixing across multiple scales and develops correlations for maintaining biologically relevant hydrodynamic conditions during scale-up. Cultures demonstrated reproducible aggregate formation, expansion, viability, and pluripotency within defined engineering ranges. The findings establish relationships between reactor scale, agitation, and cell…
PBS-15 Parts - (selected parts are added to cart for quote requests)
Loading part numbers…
We Support You Every Step of the Way
Our application scientists help you get the most out of PBS-15, and help you plan for the steps that come next.
Our application scientists optimize cell yield and quality on PBS-15 with you.
Equivalent set points from PBS-15 to PBS-80, CFD-validated at every step.
Guided-optimization packages that move you from R&D to clinical scale.
Go Vertical, Today
Tell us what you need and we’ll take it from there.